The role of antibody expression and their association with bladder cancer recurrence: a single-centre prospective clinical-pilot study in 35 patients

BACKGROUND: Bladder cancer (BC) is the 10th most common cancer in the UK, with about 10,000 new cases annually. About 75–85% of BC are non-muscle invasive (NMIBC), which is associated with high recurrence and progression rates (50–60% within 7–10 years). There are no routine biomarkers currently ava...

Descripción completa

Detalles Bibliográficos
Autores principales: Ella-Tongwiis, Peter, Lamb, Rebecca May, Makanga, Alexander, Shergill, Iqbal, Hughes, Stephen Fôn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690172/
https://www.ncbi.nlm.nih.gov/pubmed/33238953
http://dx.doi.org/10.1186/s12894-020-00759-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690172/
https://www.ncbi.nlm.nih.gov/pubmed/33238953
http://dx.doi.org/10.1186/s12894-020-00759-3

Ejemplares similares